A nationwide cross-sectional study using a web-based questionnaire survey of the duration of isolation of COVID-19 inpatients with cancer at Japanese cancer centers.

Itoh, Naoya; Akazawa, Nana; Kurai, Hanako; Kawamura, Ichiro; Okinaka, Keiji; Fujita, Takahiro; Sekiya, Noritaka; Takeda, Koichi; Shiotsuka, Mika; Ishikane, Masahiro; Iwamoto, Noriko; Ohmagari, Norio; Suzuki, Tadaki

Itoh, Naoya; Akazawa, Nana; Kurai, Hanako; Kawamura, Ichiro; Okinaka, Keiji; Fujita, Takahiro; Sekiya, Noritaka; Takeda, Koichi; Shiotsuka, Mika; Ishikane, Masahiro; Iwamoto, Noriko; Ohmagari, Norio; Suzuki, Tadaki.

Affiliation

Itoh N; Division of Infectious Diseases, Aichi Cancer Center, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan. Electronic address: itohnaoya0925@ybb.ne.jp.
Akazawa N; Division of Infectious Diseases, Aichi Cancer Center, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan.
Kurai H; Division of Infectious Diseases, Shizuoka Cancer Center Hospital, Japan.
Kawamura I; Department of Infectious Diseases, Osaka International Cancer Institute, Osaka, Japan.
Okinaka K; Division of Infectious Diseases, National Cancer Center Hospital East, Chiba, Japan.
Fujita T; Department of Infectious Diseases, National Hospital Organization Hokkaido Cancer Center, Shiroishi-ku, Sapporo, Hokkaido, Japan.
Sekiya N; Department of Infection Prevention and Control, Department of Clinical Laboratory, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Japan.
Takeda K; Department of Infectious Diseases, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Shiotsuka M; Department of Infectious Diseases, National Cancer Center Hospital, Tokyo, Japan.
Ishikane M; Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
Iwamoto N; Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
Ohmagari N; Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan.
Suzuki T; Department of Pathology, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan.

J Infect Chemother ; 29(12): 1185-1188, 2023 Dec.

Article de En | MEDLINE | ID: mdl-37541327

Mots clés

COVID-19; Cancer; Immunodeficiency; Isolation period; SARS-CoV-2

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Observational_studies / Prevalence_studies Langue: En Journal: J Infect Chemother Sujet du journal: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Année: 2023 Type de document: Article Pays de publication: Pays-Bas

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google